drugset / Trial / NCT00924534
A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess safety, tolerability, pharmacokinetics and pharmacodynamics of SLV337 in patients with type 2 diabetes
Timeline
- Start
- 2009-12
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLV337 | Unknown | 400 mg | — |
| Subject | SLV337 | Unknown | 800 mg | — |
| Subject | SLV337 | Unknown | 1400 mg | — |